BAMCO Inc
JUNO

BAMCO Inc’s Juno Therapeutics, Inc. JUNO Stock Holding History

BAMCO Inc’s Portfolio JUNO Stock Details JUNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-443,107
Closed -$13.3M – 342
2016
Q3 		$13.3M Buy
443,107
+342,582
+341% +$10.7M 0.07% 184
2016
Q2 		$3.86M Buy
+100,525
New +$4.17M 0.02% 220
2016
Q1 		– Sell
-200,000
Closed -$8.79M – 327
2015
Q4 		$8.79M Hold
200,000
– – 0.04% 215
2015
Q3 		$8.14M Buy
+200,000
New +$8.77M 0.04% 222
2015
Q1 		– Sell
-35,000
Closed -$1.83M – 375
2014
Q4 		$1.83M Buy
+35,000
New +$1.57M 0.01% 296

Other funds holding JUNO

CM
Crestline Management Fort Worth, Texas $53.5M AUM 80.67% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BCM
Biomark Capital Management Greenwich, Connecticut $8.9M AUM 97.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc's JUNO Position: Q4 2016 in Review

BAMCO Inc sold out of Juno Therapeutics, Inc. (JUNO) in Q4 2016, closing a stake of 443,107 shares — an estimated $13.3M sold.

BAMCO Inc first reported a position in JUNO in Q4 2014 and held it in 5 quarters. The position peaked at $13.3M in Q3 2016. 159 funds tracked by Wall St. Rank hold JUNO as of Q4 2016.

  • BAMCO Inc reported no remaining Juno Therapeutics, Inc. position as of Q4 2016 after selling out during the quarter.
  • BAMCO Inc sold 443,107 Juno Therapeutics, Inc. shares in Q4 2016, an estimated $13.3M.
  • BAMCO Inc first reported a position in Juno Therapeutics, Inc. in Q4 2014 and held it in 5 quarters.
  • BAMCO Inc's Juno Therapeutics, Inc. position peaked at $13.3M in Q3 2016.
  • 159 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q4 2016.

Based on BAMCO Inc's 13F filing for Q4 2016, filed 14 Feb 2017.